APEMARS Presale Stage 22 Claims 1039% ROI After Listing
APEMARS presale is in Stage 22 (“SURFACE SYNC”), with the article claiming strong momentum ahead of listing. The presale token price is set at $0.00048248, while the projected listing target is $0.0055.
Updated metrics cited include 1,795+ holders, $485K+ raised, and roughly 30.56B tokens sold. Tokenomics are described as deflationary (a burn mechanism reducing supply) plus staged distribution to limit immediate sell pressure.
For traders, the promotional scenario is central: a $7,000 buy in APEMARS presale Stage 22 could yield about 14.51M APRZ tokens before bonuses, translating to an estimated ~1039% ROI at the listing target. The piece also promotes staking via “Ape Yield Station,” claiming up to ~63% APY with lock periods tied to a rewards pool.
Timing mechanics are emphasized: allocation availability and a countdown are said to determine when the entry window closes. The article is framed as a sponsored press release, and ROI figures should be treated as marketing estimates rather than verified guidance.
Related meme-cycle context is referenced (DOGE, PEPE) alongside other engagement/market names (notably ParaWin/PWIN), but the direct trade focus remains APEMARS presale into the listing window—where hype-driven inflows can raise volatility even without independent confirmation.
Bullish
The update reinforces a near-term attention catalyst for APEMARS: Stage 22 progress, higher buyer count, and the concrete narrative of a priced listing target ($0.00048248 → $0.0055). Promotional ROI and a claimed staking APY can attract speculative inflows, which typically increases demand and short-term volatility around presale-to-listing transitions.
However, because the figures come from a sponsored press release and the ROI math is not independently verified, the “bullish” bias is mainly about flows into APEMARS presale rather than confirmed fundamentals. This can still be tradable, but it raises risk of rapid reversals if the listing timeline, token mechanics, or burn/lock claims are questioned.